Rosycap-ASP 20/75 Capsule is a combination medicine used to manage high cholesterol and protect against heart disease. It contains Rosuvastatin 20mg, which lowers cholesterol, and Aspirin 75mg, which helps prevent blood clots. This combination provides stronger protection for people at higher risk of cardiovascular events.
It is commonly prescribed for patients with high cholesterol who are at risk of heart attack, stroke, or have a history of heart disease.
Benefits
-
Reduces bad cholesterol (LDL) and triglycerides
-
Increases good cholesterol (HDL)
-
Prevents blood clots in arteries
-
Lowers the risk of heart attack and stroke
-
Combines cholesterol-lowering and anti-clotting benefits in one capsule
Possible Side Effects
Some common side effects may include:
-
Stomach discomfort, acidity, or nausea
-
Muscle pain or weakness
-
Headache or dizziness
-
Easy bruising or bleeding
Seek medical attention if you notice black or tarry stools, persistent muscle pain, unusual bleeding, or yellowing of the skin/eyes.
How to Use
Take Rosycap-ASP 20/75 Capsule exactly as prescribed by your doctor. Swallow it whole with water, preferably at the same time each day. Do not chew, crush, or split the capsule.
How It Works
-
Rosuvastatin 20mg lowers cholesterol production in the liver, reducing LDL and triglycerides while raising HDL.
-
Aspirin 75mg prevents platelets from clumping, lowering the risk of blood clots.
Together, they help maintain healthy blood vessels and protect the heart from complications caused by cholesterol and clots.
Safety Information
-
Alcohol: Limit or avoid, as it may increase stomach and liver side effects
-
Pregnancy & Breastfeeding: Not safe; should not be used
-
Driving: Usually safe, but avoid if you feel dizzy
-
Kidney & Liver: Use with caution; dose adjustments may be needed in patients with kidney or liver disease
Missed Dose
If you miss a dose, take it as soon as you remember. If it is nearly time for the next dose, skip the missed one. Do not take two doses together.
Reviews
There are no reviews yet.